Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2' patients

BACKGROUND: In metastatic colorectal cancer, the modified Glasgow prognostic score (mGPS) has been approved as an independent prognostic indicator of survival. No data existed on poor prognosis patients treated with molecular-targeted agents. METHODS: From January 2007 to February 2012, patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Dréanic, Johann, Dhooge, Marion, Barret, Maximilien, Brezault, Catherine, Mir, Olivier, Chaussade, Stanislas, Coriat, Romain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575554/
https://www.ncbi.nlm.nih.gov/pubmed/26401469
http://dx.doi.org/10.1002/jcsm.12022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575554/
https://www.ncbi.nlm.nih.gov/pubmed/26401469
http://dx.doi.org/10.1002/jcsm.12022

Ejemplares similares